Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the last session and the average volume of the stock remained … Continue reading Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

Biotech Active Stocks: Pfizer Inc. (NYSE:PFE), Geron Corporation (NASDAQ:GERN), Cell Therapeutics (NASDAQ:CTIC), Chelsea Therapeutics International (NASDAQ:CHTP)

A US federal court yesterday invalidated Pfizer Inc.’s (NYSE:PFE) key patent covering its anti-inflammatory pill Celebrex. The patent, which was set to lapse in December 2015, would have given Pfizer an 18-month extension from the expiry of the patent for the major ingredient in the drug, celecoxib. Pfizer Inc. (NYSE:PFE) stock performance was -2.69% in last session and finished the day at $31.12. Traded volume … Continue reading Biotech Active Stocks: Pfizer Inc. (NYSE:PFE), Geron Corporation (NASDAQ:GERN), Cell Therapeutics (NASDAQ:CTIC), Chelsea Therapeutics International (NASDAQ:CHTP)

Biopharmaceutical giant Oxigene Inc (NASDAQ:OXGN) y reported its experimental drug Zybrestat, combined with Roche’s cancer drug Avastin, significantly slowed progression of recurrent ovarian cancer. OXiGENE Inc (NASDAQ:OXGN) stock performance was 77.27% in last session and finished the day at $4.29. Traded volume was 29,290,814 million shares in the last session and the average volume of the stock remained 569.72 million shares. The beta of the … Continue reading Biotech Top Gainers: OXiGENE Inc (NASDAQ:OXGN), Cell Therapeutics Inc (NASDAQ:CTIC), Arca Biopharma Inc (NASDAQ:ABIO), NPS Pharmaceuticals (NASDAQ:NPSP)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was -5.69% in last session and finished the day at $29.48. Traded volume was 263,884 million shares in the last session and the average volume of the stock remained 254.15 million shares. Agios Pharmaceuticals Inc (NASDAQ:AGIO) insider ownership … Continue reading Biotech Losers In News: Agios Pharmaceuticals (NASDAQ:AGIO), Cell Therapeutics (NASDAQ:CTIC), NewLink Genetics (NASDAQ:NLNK), Mirati Therapeutics (NASDAQ:MRTX)

On Nov 24, Conversant (NASDAQ:CNVR) and its premium video media solutions group, SET by Conversant, today announced it has been awarded Best Paper for Storytelling with Images and Videos (VisStory) for its paper entitled “Unsupervised Summarization from Simultaneous Egocentric Videos,” at the ECCV 2014 in Zurich, Switzerland. The award-winning paper highlights pioneering research that Conversant is delivering in the field of computer vision. Conversant, Inc. … Continue reading Trending Tickers: Conversant, Inc. (NASDAQ:CNVR), CNinsure Inc. (NASDAQ:CISG), CTI BioPharma Corp. (NASDAQ:CTIC), Fresenius Medical Care AG & Co. (NYSE:FMS), MOCON Inc. (NASDAQ:MOCO)

Wells Fargo & Co. reiterated their underperform rating on shares of Seadrill (NASDAQ:SDRL) in a research report released on Wednesday morning. SeaDrill Limited (NYSE:SDRL) shares fell -2.43% in last trading session and ended the day at $24.85. SDRL Gross Margin is 57.90% and its return on assets is 15.90%. SeaDrill Limited (NYSE:SDRL) quarterly performance is -36.51%. On Sep 16, GreenHunter Resources, Inc. (NYSEMKT:GRH), announced that … Continue reading Today’s Watch List : SeaDrill Limited (NYSE:SDRL), GreenHunter Resources, Inc. (NYSEMKT:GRH), CTI BioPharma Corp. (NASDAQ:CTIC), Eli Lilly and Company (NYSE:LLY), TSLA